Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients

2009 ◽  
Vol 23 (3) ◽  
pp. 351-360 ◽  
Author(s):  
S. Demirjian ◽  
B. Stephany ◽  
I.S. Abu Romeh ◽  
M. Boumitri ◽  
M.H. Yamani ◽  
...  
Keyword(s):  
Lung Transplant ◽  
Calcineurin Inhibitor ◽  
Renal Outcome ◽  
Transplant Recipients ◽  
Lung Transplant Recipients

Looking Beyond the Allograft Survival: Long-Term, 5-Year Renal Outcome in Lung Transplant Recipients

2021 ◽  
Author(s):  
Mohankumar Doraiswamy ◽  
Eshetu Obole ◽  
Mena Botros ◽  
Brian C. Keller ◽  
Todd Pesavento ◽  
...  
Keyword(s):  
Lung Transplant ◽  
Renal Outcome ◽  
Transplant Recipients ◽  
Allograft Survival ◽  
Lung Transplant Recipients

scholarly journals Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: Results of a controlled pilot study

2005 ◽  
Vol 67 (4) ◽  
pp. 1471-1475 ◽  
Author(s):  
David Shitrit ◽  
Ruth Rahamimov ◽  
Sahar Gidon ◽  
Ilana Bakal ◽  
Ariella Bargil-Shitrit ◽  
...  
Keyword(s):  
Pilot Study ◽  
Renal Impairment ◽  
Lung Transplant ◽  
Low Dose ◽  
Calcineurin Inhibitor ◽  
Transplant Recipients ◽  
Lung Transplant Recipients

Everolimus as a Calcineurin Inhibitor-Sparing Immunosuppressive Agent in Lung Transplant Recipients With Renal Impairment

CHEST Journal ◽  
2017 ◽  
Vol 152 (4) ◽  
pp. A1098
Author(s):  
Shaun Yo ◽  
Tim Coughlan ◽  
Steve Ivulich ◽  
Eldho Paul ◽  
Gregory Snell ◽  
...  
Keyword(s):  
Renal Impairment ◽  
Lung Transplant ◽  
Calcineurin Inhibitor ◽  
Immunosuppressive Agent ◽  
Transplant Recipients ◽  
Lung Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document